N. Eggmann

Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study

Reinhard Dummer, Simone M. Goldinger, Christian P. Turtschi et al. · European Journal of Cancer · 2013 · 286 citations

Neuro-oncology, Open-label Pilot Study, Medicine +8

Long-Term Recurrence Rate of Large and Difficult to Treat Cutaneous Squamous Cell Carcinomas after Superficial Radiotherapy

Marjam J. Barysch, N. Eggmann, Mirjam Beyeler et al. · Dermatology · 2012 · 44 citations · Full text

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)

Reinhard Dummer, Madeleine Duvic, Julia Scarisbrick et al. · Annals of Oncology · 2014 · 42 citations · Full text

Lymphoid Neoplasia, Medicine, Immunodeficiencies +11

Lichenoid Drug Eruptionfollowing Intravenous Applicationof Orally Formulated Diamorphine, a Semisynthetic Heroin

Isabel Kolm, N. Eggmann, Jivko Kamarashev et al. · Case Reports in Dermatology · 2013 · 24 citations · Full text

Open-Label Pilot Study of Vemurafenib in Previously Treated Metastatic Melanoma (MM) Patients (PTS) with Symptomatic Brain Metastases (BM)

Reinhard Dummer, Simone M. Goldinger, Christian P. Turtschi et al. · Annals of Oncology · 2012 · 14 citations

Open-label Pilot Study, Medicine, Melanoma +6